One study found that weekly treatment with semaglutide, a GLP-1 RA, reduced the risk of a combination of stroke, heart attack, and death from cardiovascular causes by 20% compared with placebo.
The medication itself doesnt cause people to lose fluids, but similar to the way that GLP-1s quiet the bodys hunger signals, they can also dampen thirst signals, he explains
Which Weight Loss Surgeries Are Covered
Whether you're under Medicaid, Aetna, Blue Cross Blue Shield, UnitedHealthcare, or Cigna, Klinic assists in verifying coverage and managing necessary prior authorizations
Skin tightening procedures can only do so much
Regulators have already extended GLP-1 approvals beyond weight and glucose management into cardiovascular risk reduction and sleep apnea, and ongoing trials are examining kidney disease, liver disease, and other conditions